Government announces cannabis-derived medicinal products to be made available on perscription

We welcome the announcement made today that cannabis-derived medicinal products are to be made available under prescription. It marks another monumental step forward for the campaign for access to medical cannabis under prescription. We now need clarity from the government on exactly what medicines will be available and how they will be regulated.  Ending up with only a limited range of derived cannabis products that are all required to have been through full pharma level trials will be a huge disappointment and be a missed opportunity.  The best outcome for UK patients would be the introduction of a special category for medical cannabis.  Products in this category could include many of the wide range of whole plant cannabis oils, as long as they are manufactured to a consistent standard, that are currently available in many other countries.